Acute hepatitis caused by alverine associated with anti-lamin A and C autoantibodies

Journal of Hepatology

Volumn 27, Issue 2, 1997, Pages 399-403

  Malka, David ^c   Pham, Bach Nga ^a   Courvalin, Jean Claude ^b   Corbic, Michèle ^c   Pessayre, Dominique ^c   Erlinger, Serge ^c  

^a BEAUJON HOSPITAL   (France)

^b INSTITUT JACQUES MONOD   (France)

^c NONE

Author keywords

Alverine; Antinuclear antibodies; Autoantibodies; Drug induced hepatitis; Lamin

Indexed keywords

ALVERINE; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; ISPAGULA; LAMIN A; LAMIN C; SPASMOLYTIC AGENT;

ACUTE HEPATITIS; AGED; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG INDUCED DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IRRITABLE COLON; LIVER TOXICITY; PRIORITY JOURNAL;

EID: 0030747377     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80187-0     Document Type: Article

References (33)

1. Pessayre D, Larrey D. Drug-induced liver injury. McIntyre N, Benhamou JP, Bircher J, Rizetto M, Rodes J. Oxford Textbook of Clinical Hepatology. 1992;875-902 Oxford University Press, Oxford.
2. 72nd Edn. Vidal 1996. 1996;Editions Vidal, Paris.
3. Farrell GC. Drug Induced Liver Disease. 1994;Churchill Livingstone, Edinburgh, London, Madrid, Melbourne, New York and Tokyo.
4. Hombeg JC, Abuaf N, Helmy-Khalil S, Biour M, Poupon R, Islam S, et al. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology. 5:1985;722-727.
5. Homberg JC, Stelly N, Andreis I, Abuaf N, Saadoun F, Andre J. A new antimitochondrial antibody (anti-M6) in iproniazid-induced hepatitis. Clin Exp Immunol. 47:1982;93-102.
6. Bourdi M, Larrey D, aiNataf J, Pessayre D, Iwasaki M, Guengerich FP, et al. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. J Clin Invest. 85:1990;1967-1973.
7. Beaune P, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, et al. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci USA. 84:1987;551-555.
8. Reynolds TB, Peters RL, Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med. 280:1971;813-820.
9. Toghill PJ, Smith PG, Benton P, Brown RC, Matthews HL. Methyldopa liver damage. Br Med J. 3:1974;545-548.
10. Iwarson S, Lindberg J, Lunden P. Nitrofurantoin-induced chronic liver disease. Clinical course and outcome of five cases. Scand J Gastroenterol. 14:1979;497-450.
11. Martinot-Peignoux M, Marcellin P, Xu LZ, Benhamou JP, Larzul D. Reactivity to c33c antigen as a marker of hepatitis C virus multiplication. J Infect Dis. 19:1992;1337-1341.
12. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khadil SH, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology. 7:1987;1333-1339.
13. Courvalin JC, Lassoued K, Bartnik E, Blobel G, Wozniak RW. The 210 kilodalton nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest. 85:1990;279-285.
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriopage T4. Nature. 227:1970;680-685.
15. Danan G. Consensus meetings on causality assessment of drug-induced liver injury. J Hepatol. 7:1988;132-136.
16. Ronnov-Jessen V, Tjernlund A. Hepatotoxicity due to treatment with papaverine: report of four cases. N Engl J Med. 281:1969;1333-1335.
17. Kiaer HW, Olsen S, Ronnov-Jessen V. Hepatotoxicity of papaverine. Arch Pathol. 98:1974;292-296.
18. Poupon R, Longchal C, Darnis F. Hépatitic chronique associée à la prise prolongée de papavérine. Gastroenterol Clin Biol. 2:1978;305-308.
19. Poncin E, Sylvain C, Touchard G, Barbier J, Beauchant M. Papaverine-induced chronic liver disease. Gastroenterology. 90:1986;1051-1053.
20. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 144:1989;93-151.
21. Worman HJ, Courvalin JC. Autoantibodies against nuclear envelope proteins in liver disease. Hepatology. 14:1991;1269-1279.
22. Lassoued K, Guilly MN, André C, Paintrand M, Dhumeaux D, Danon F, et al. Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. Clin Exp Immunol. 74:1988;283-288.
23. Lassoued K, Brenard R, Degos F, Courvalin JC, Andre C, Danon F, et al. Antinuclear antibodies directed to a 200-kilo-dalton polypeptide of the nuclear envelope in primary biliary cirrhosis. Gastroenterology. 99:1990;181-186.
24. Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology. 110:1996;840-847.
25. Reeves WH, Chaudhary N, Salerno A, Blobel G. Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus. J Exp Med. 165:1987;750-762.
26. Konstantinov K, Halberg P, Wiik A, Moier-Madsen M, Wantzin P, Ullman S, et al. Clinical manifestations in patients with autoantibodies specific for nuclear lamin proteins. Clin Immunol Immunophathol. 62:1992;112-118.
27. Lassoued S, Oksman E, Fournie B, Danon F, Fournie A, Lassoued K. Autoantibodies to lamins in rheumatoid arthritis. Arthritis Rheum. 33:1990;877-879.
28. Wesierska-Gadek J, Penner E, Hitchman E, Sauermann G. Antibodies to nuclear lamins in autoimmune liver disease. Clin Immunol Immunopathol. 49:1988;107-115.
29. Lassoued K, Guilly MN, Danon F, Andre C, Dhumeaux D, Clauvel JP, et al. Antinuclear autoantibodies specific for lamins. Characterization and clinical significance. Ann Intern Med. 108:1988;829-833.
30. McKeon FD, Tuffanelli DL, Fukuyama K, Kirschner MW. Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc Natl Acad Sci USA. 80:1983;4374-4378.
31. Guilly MN, Danon F, Brouet JC, Bornens M, Courvalin JC. Antoantibodies to nuclear lamin B in a patient with thrombocytopenia. Eur J Cell Biol. 43:1987;266-272.
32. Wesierska-Gadek J, Penner E, Hitchman E, Sauermann G. Antibodies to nuclear lamin C in chronic hepatitis delta virus infection. Hepatology. 12:1990;1129-1133.
33. Courvalin JC, Chaudhary N, Danon F, Brouet JC, Lassoued K. Characterization of human autoantibodies specific for lamin A. Biol Cell. 69:1990;93-97.